20 (AIDX) Depreciation & Amortization (CF) (2025 - 2026)
20's (AIDX) quarterly Depreciation & Amortization (CF) came in at $12306.0 in Q1 2026, down 30.96% YoY from $17825.0 in Q1 2025, and down 30.96% on a QoQ basis from $17825.0 in Q1 2025.
20 (AIDX) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $12306.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 30.96% year-over-year to $12306.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30131.0 (changed N/A YoY) and the FY2025 annual result came in at $63257.0, down 45.48% from the prior year.
- Depreciation & Amortization (CF) retreated to $12306.0 in Q1 2026, from $17825.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $17825.0 in Q1 2025 to a low of $12306.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 123.80 Mn |
| 10 | 20 | 5.55 Mn | 1.00 Mn | 304,727.00 | 12,304.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,306.00 |
| Mar 31, 2026 | 12,306.00 |
| Mar 31, 2025 | 17,825.00 |
| Mar 31, 2025 | 17,825.00 |